Literature DB >> 11418416

Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage?

J F Deux1, M Bazot, A F Le Blanche, M Tassart, A Khalil, N Berkane, S Uzan, F Boudghène.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of selective arterial embolization to control severe postpartum hemorrhage.
MATERIALS AND METHODS: Twenty-five women with intractable postpartum hemorrhage underwent uterine embolization in our institution during a 6-year period.
RESULTS: Angiography revealed arterial extravasation in 13 patients (52%). Sixty-nine arteries were embolized. External bleeding resolved immediately or was markedly decreased in 24 women. In one patient, embolization failed to control the bleeding, and surgical treatment was required. No major complication of embolization therapy was observed. Ten women were followed up for an average of 2 years. Menstruation resumed in all patients, and one woman became pregnant.
CONCLUSION: Embolization of acute postpartum hemorrhage is a safe and effective alternative to hysterectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11418416     DOI: 10.2214/ajr.177.1.1770145

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Emergency peripartum hysterectomy in a tertiary care hospital in saudi arabia.

Authors:  Mahfuza Begum; Faisal Alsafi; Jamil ElFarra; Hani M Tamim; Tien Le
Journal:  J Obstet Gynaecol India       Date:  2013-07-12

Review 2.  Pelvic Artery Embolization for Treatment of Postpartum Hemorrhage.

Authors:  Jonathan D Lindquist; Robert L Vogelzang
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

3.  Menses recovery and fertility after artery embolization for PPH: a single-center retrospective observational study.

Authors:  G Gaia; P Chabrot; L Cassagnes; A Calcagno; D Gallot; R Botchorishvili; M Canis; G Mage; L Boyer
Journal:  Eur Radiol       Date:  2008-09-03       Impact factor: 5.315

4.  Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines.

Authors:  Miyuki Sone; Yasuo Nakajima; Reiko Woodhams; Yasukazu Shioyama; Masakatsu Tsurusaki; Takao Hiraki; Misako Yoshimatsu; Hideki Hyodoh; Takahiko Kubo; Satoru Takeda; Hisanori Minakami
Journal:  Jpn J Radiol       Date:  2015-02-19       Impact factor: 2.374

5.  Internal Iliac Artery Embolisation in Post LSCS Haemorrhage.

Authors:  Sushil Kumar; J D Souza; I K Indrajit; V Mohindra; Maj Rima
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Postpartum haemorrhage due to genital tract injury after vaginal delivery: safety and efficacy of transcatheter arterial embolisation.

Authors:  Sang Min Lee; Ji Hoon Shin; Jong Joon Shim; Ki Woong Yoon; Young Jong Cho; Jong Woo Kim; Heung Kyu Ko
Journal:  Eur Radiol       Date:  2018-05-28       Impact factor: 5.315

7.  Acquired uterine vascular malformations: radiological and clinical outcome after transcatheter embolotherapy.

Authors:  Geert Maleux; Dirk Timmerman; Sam Heye; Guy Wilms
Journal:  Eur Radiol       Date:  2005-06-24       Impact factor: 5.315

8.  Severe postpartum haemorrhage from ruptured pseudoaneurysm: successful treatment with transcatheter arterial embolization.

Authors:  Philippe Soyer; Yann Fargeaudou; Olivier Morel; Mourad Boudiaf; Olivier Le Dref; Roland Rymer
Journal:  Eur Radiol       Date:  2008-02-13       Impact factor: 5.315

9.  Arterial catheterization and embolization for management of emergent or anticipated massive obstetrical hemorrhage.

Authors:  Daiji Uchiyama; Masamichi Koganemaru; Toshi Abe; Daizou Hori; Naofumi Hayabuchi
Journal:  Radiat Med       Date:  2008-05-29

Review 10.  Short & long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review.

Authors:  Marie-Aimée Päivi Soro; Alban Denys; Maud de Rham; David Baud
Journal:  Eur Radiol       Date:  2016-05-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.